Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial.

Additional genomic findings Diagnostic sequencing Genomic sequencing Randomized controlled trial Test-related distress

Journal

Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280

Informations de publication

Date de publication:
12 2021
Historique:
received: 21 01 2021
revised: 31 03 2021
accepted: 22 04 2021
pubmed: 11 5 2021
medline: 1 2 2022
entrez: 10 5 2021
Statut: ppublish

Résumé

Many people prefer to learn secondary or "additional" findings from genomic sequencing, including findings with limited medical actionability. Research has investigated preferences for and effects of learning such findings, but not psychosocial and behavioral effects of receiving education about them and the option to request them, which could be burdensome or beneficial (e.g., causing choice overload or satisfying strong preferences, respectively). 335 adults with suspected genetic disorders who had diagnostic exome sequencing in a research study and were randomized to receive either diagnostic findings only (DF; n = 171) or diagnostic findings plus education about additional genomic findings and the option to request them (DF + EAF; n = 164). Assessments occurred after enrollment (Time 1), after return of diagnostic results and-for DF + EAF-the education under investigation (Time 2), and three and six months later (Times 3, 4). Time 2 test-related distress, test-related uncertainty, and generalized anxiety were lower in the DF + EAF group (ps = 0.025-0.043). There were no other differences. Findings show limited benefits and no harms of providing education about and the option to learn additional findings with limited medical actionability. Findings can inform recommendations for returning additional findings from genomic sequencing (e.g., to research participants or after commercial testing).

Identifiants

pubmed: 33966955
pii: S0738-3991(21)00291-3
doi: 10.1016/j.pec.2021.04.026
pmc: PMC8553797
mid: NIHMS1700076
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01969370']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Pagination

2989-2998

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG006487
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of interest None.

Auteurs

Christine Rini (C)

Department of Medical Social Sciences, Northwestern University, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA. Electronic address: christine.rini@northwestern.edu.

Myra I Roche (MI)

Department of Pediatrics, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.

Feng-Chang Lin (FC)

Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, USA.

Ann Katherine M Foreman (AKM)

Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.

Cynthia M Khan (CM)

U.S. Government Accountability Office, 441G Street NW, Washington, DC 20548, USA.

Ida Griesemer (I)

Department of Health Behavior, University of North Carolina, 135 Dauer Dr., Chapel Hill, NC 27599, USA.

Margaret Waltz (M)

Department of Social Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.

Kristy Lee (K)

Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.

Julianne M O'Daniel (JM)

Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.

James P Evans (JP)

Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.

Jonathan S Berg (JS)

Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.

Gail E Henderson (GE)

Department of Social Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH